LSV Asset Management Sells 3,500 Shares of Prestige Consumer Healthcare Inc. $PBH

LSV Asset Management cut its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 32.1% during the second quarter, HoldingsChannel.com reports. The firm owned 7,400 shares of the company’s stock after selling 3,500 shares during the quarter. LSV Asset Management’s holdings in Prestige Consumer Healthcare were worth $591,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Kayne Anderson Rudnick Investment Management LLC raised its stake in shares of Prestige Consumer Healthcare by 45.3% during the first quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,580,819 shares of the company’s stock worth $135,903,000 after buying an additional 493,199 shares during the last quarter. Invesco Ltd. grew its holdings in Prestige Consumer Healthcare by 24.7% during the 1st quarter. Invesco Ltd. now owns 1,321,800 shares of the company’s stock worth $113,635,000 after acquiring an additional 261,537 shares during the period. Tributary Capital Management LLC acquired a new stake in Prestige Consumer Healthcare during the 2nd quarter worth $11,773,000. Goldman Sachs Group Inc. raised its position in shares of Prestige Consumer Healthcare by 28.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 546,672 shares of the company’s stock valued at $46,997,000 after acquiring an additional 120,965 shares during the last quarter. Finally, Neumeier Poma Investment Counsel LLC bought a new stake in shares of Prestige Consumer Healthcare during the 1st quarter valued at $8,713,000. Institutional investors and hedge funds own 99.95% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Prestige Consumer Healthcare in a research note on Wednesday, October 8th. Oppenheimer reduced their target price on Prestige Consumer Healthcare from $82.00 to $72.00 and set an “outperform” rating on the stock in a report on Tuesday, October 21st. Zacks Research upgraded Prestige Consumer Healthcare from a “strong sell” rating to a “hold” rating in a research report on Monday, November 10th. Wall Street Zen downgraded shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, August 9th. Finally, Canaccord Genuity Group reduced their price objective on shares of Prestige Consumer Healthcare from $100.00 to $88.00 and set a “buy” rating on the stock in a research note on Friday, November 7th. Four research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $85.33.

Prestige Consumer Healthcare Trading Up 0.4%

NYSE:PBH opened at $59.43 on Friday. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.38 and a quick ratio of 2.99. The business’s 50-day simple moving average is $61.74 and its 200-day simple moving average is $71.73. Prestige Consumer Healthcare Inc. has a fifty-two week low of $58.03 and a fifty-two week high of $90.04. The stock has a market capitalization of $2.86 billion, a PE ratio of 13.95, a price-to-earnings-growth ratio of 1.93 and a beta of 0.41.

Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Thursday, November 6th. The company reported $1.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.97 by $0.10. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.The business had revenue of $274.11 million during the quarter, compared to analysts’ expectations of $257.14 million. During the same period in the prior year, the business earned $1.09 EPS. Prestige Consumer Healthcare’s revenue for the quarter was down 3.4% compared to the same quarter last year. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.540-4.580 EPS. Sell-side analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.